These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3177375)

  • 21. Formation of Charcot-Leyden crystals by human basophils.
    Ackerman SJ; Weil GJ; Gleich GJ
    J Exp Med; 1982 Jun; 155(6):1597-609. PubMed ID: 7042896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Charcot-Leyden crystal protein in the degranulation and recovery of activated basophils.
    Golightly LM; Thomas LL; Dvorak AM; Ackerman SJ
    J Leukoc Biol; 1992 Apr; 51(4):386-92. PubMed ID: 1373430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Charcot-Leyden crystal protein (galectin-10) is not a dual function galectin with lysophospholipase activity but binds a lysophospholipase inhibitor in a novel structural fashion.
    Ackerman SJ; Liu L; Kwatia MA; Savage MP; Leonidas DD; Swaminathan GJ; Acharya KR
    J Biol Chem; 2002 Apr; 277(17):14859-68. PubMed ID: 11834744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic eosinophilic leukemia presenting with autoimmune hemolytic anemia and erythrophagocytosis by eosinophils.
    Kuk JS; Maceachern JA; Soamboonsrup P; McFarlane A; Benger A; Patterson W; Yang L; Trus MR
    Am J Hematol; 2006 Jun; 81(6):458-61. PubMed ID: 16680737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of Charcot-Leyden crystals by fluorescence microscopy of Papanicolaou-stained smears of sputum, bronchoalveolar lavage fluid, and bronchial secretions.
    Küpper T; Spies S; Wehle K; Pfitzer P
    Cytopathology; 1994 Oct; 5(5):262-9. PubMed ID: 7529587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Charcot-Leyden crystals: do they exist in veterinary species? A case report and literature review.
    Choi E; Miller AD; Devenish E; Asakawa M; McConkey M; Peters-Kennedy J
    J Vet Diagn Invest; 2017 Nov; 29(6):904-909. PubMed ID: 28782436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Charcot-Leyden Crystals in Eosinophilic Inflammation: Active Cytolysis Leads to Crystal Formation.
    Ueki S; Miyabe Y; Yamamoto Y; Fukuchi M; Hirokawa M; Spencer LA; Weller PF
    Curr Allergy Asthma Rep; 2019 Jun; 19(8):35. PubMed ID: 31203469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Charcot Leyden crystals in synovial fluid.
    del Blanco J; Valverde J; Mateo L; Juanola X; Pons M; Ferrer J
    J Rheumatol; 1991 Dec; 18(12):1944. PubMed ID: 1795344
    [No Abstract]   [Full Text] [Related]  

  • 29. Selective recognition of mannose by the human eosinophil Charcot-Leyden crystal protein (galectin-10): a crystallographic study at 1.8 A resolution.
    Swaminathan GJ; Leonidas DD; Savage MP; Ackerman SJ; Acharya KR
    Biochemistry; 1999 Oct; 38(42):13837-43. PubMed ID: 10529229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Charcot-Leyden crystals and bone marrow necrosis in acute myeloid leukemia.
    Radujkovic A; Bellos F; Andrulis M; Ho AD; Hundemer M
    Eur J Haematol; 2011 May; 86(5):451-2. PubMed ID: 21342270
    [No Abstract]   [Full Text] [Related]  

  • 31. Charcot-Leyden crystal protein and eosinophil granule major basic protein in sputum of patients with respiratory diseases.
    Dor PJ; Ackerman SJ; Gleich GJ
    Am Rev Respir Dis; 1984 Dec; 130(6):1072-7. PubMed ID: 6508005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Charcot-Leyden crystals in chronic eosinophilic leukemia.
    Sandberg Y; Weerkamp F
    Blood; 2021 Apr; 137(14):1985. PubMed ID: 33830189
    [No Abstract]   [Full Text] [Related]  

  • 33. Glomerular and tubular factors in urine flow rates of acute renal failure patients.
    Rahman SN; Conger JD
    Am J Kidney Dis; 1994 Jun; 23(6):788-93. PubMed ID: 8203359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Charcot-Leyden crystals: pathology and diagnostic utility.
    Pantanowitz L; Balogh K
    Ear Nose Throat J; 2004 Jul; 83(7):489-90. PubMed ID: 15372922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eosinophilia and elevated serum levels of eosinophil major basic protein and Charcot-Leyden crystal protein (lysophospholipase) after treatment of patients with Bancroft's filariasis.
    Ackerman SJ; Gleich GJ; Weller PF; Ottesen EA
    J Immunol; 1981 Sep; 127(3):1093-8. PubMed ID: 7021674
    [No Abstract]   [Full Text] [Related]  

  • 36. FORMATION OF CHARCOT-LEYDEN CRYSTALS IN HUMAN EOSINOPHILS AND BASOPHILS AND STUDY OF THE COMPOSITION OF ISOLATED CRYSTALS.
    ARCHER GT; BLACKWOOD A
    J Exp Med; 1965 Jul; 122(1):173-80. PubMed ID: 14325469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Brief History of Charcot-Leyden Crystal Protein/Galectin-10 Research.
    Su J
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30424011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical characterization of human eosinophil Charcot-Leyden crystal protein (lysophospholipase).
    Weller PF; Bach DS; Austen KF
    J Biol Chem; 1984 Dec; 259(24):15100-5. PubMed ID: 6511787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone marrow necrosis with Charcot-Leyden crystals in a patient with idiopathic hypereosinophilic syndrome.
    Pujol-Moix N; Brunet S; Ayats R
    Haematologica; 2003 Sep; 88(9):EIM12. PubMed ID: 12969825
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinically-occult mixed cellularity Hodgkin's disease with Charcot-Leyden crystals.
    Carson HJ; Pellettiere EV
    Leuk Lymphoma; 1996 Sep; 23(1-2):153-7. PubMed ID: 9021699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.